Adiponectin is related to a higher risk of HF and mortality, particularly in non-obese individuals, and leptin and IL-6 reflect the link with non-traditional and traditional risk predictors, emphasizing the importance of managing inflammation to reduce CV risk [99,100]. This evidence concerns the gene ADIPOQ and hydrops fetalis.